Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0378 | 0 | 0.5 |
Trypanosoma cruzi | GUP1, putative | 0.0378 | 0 | 0.5 |
Trypanosoma brucei | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Toxoplasma gondii | acyl-CoA:diacylglycerol acyltransferase 1-related enzyme | 0.0378 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.0378 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0378 | 0 | 0.5 |
Echinococcus granulosus | protein cysteine N palmitoyltransferase | 0.4391 | 1 | 1 |
Trypanosoma cruzi | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Schistosoma mansoni | zinc finger protein | 0.4391 | 1 | 1 |
Leishmania major | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | 0.0979 | 0.1497 | 0.1497 |
Plasmodium falciparum | diacylglycerol O-acyltransferase | 0.0378 | 0 | 0.5 |
Loa Loa (eye worm) | MBOAT family protein | 0.4391 | 1 | 1 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0378 | 0 | 0.5 |
Echinococcus multilocularis | protein cysteine N palmitoyltransferase | 0.4391 | 1 | 1 |
Echinococcus multilocularis | zinc finger protein | 0.4013 | 0.9057 | 0.9057 |
Entamoeba histolytica | hypothetical protein, conserved | 0.0378 | 0 | 0.5 |
Leishmania major | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Onchocerca volvulus | 0.0378 | 0 | 0.5 | |
Treponema pallidum | alginate O-acetylation protein (algI) | 0.0378 | 0 | 0.5 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0378 | 0 | 0.5 |
Leishmania major | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Entamoeba histolytica | membrane-bound O-acyltransferase (MBOAT ) family protein | 0.0378 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0378 | 0 | 0.5 |
Trichomonas vaginalis | porcupine, putative | 0.0378 | 0 | 0.5 |
Leishmania major | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Trichomonas vaginalis | transmembrane protein nessy, putative | 0.0378 | 0 | 0.5 |
Trypanosoma brucei | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0378 | 0 | 0.5 |
Trypanosoma cruzi | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0378 | 0 | 0.5 |
Trypanosoma cruzi | GUP1, putative | 0.0378 | 0 | 0.5 |
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | 0.0378 | 0 | 0.5 |
Trypanosoma cruzi | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Entamoeba histolytica | vacuolar protein sorting 26 | 0.0378 | 0 | 0.5 |
Leishmania major | glycerol uptake protein, putative | 0.0378 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol O-acyltransferase, putative | 0.0378 | 0 | 0.5 |
Echinococcus granulosus | zinc finger protein | 0.4013 | 0.9057 | 0.9057 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1032 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.0787 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 16.3535 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.